The global radiofrequency ablation devices market is anticipated to grow at a CAGR of 1.5% during the forecast period. The new and innovative RF ablation devices to support minimally invasive surgeries are a key factor driving the growth of the global radiofrequency ablation devices market. The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches, and product innovation to remain competitive in the marketplace. The various product launches of the key players are as follows:
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/radiofrequency-ablation-rf-devices-market
- In November 2020, Abbott Laboratories has launched the IonicRF Generator. Iconic RF is a US FDA approved device to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
- In February 2019, Medtronic Plc has launched the new Accurian radio frequency (RF) ablation system in the US, following 510(k) clearance from the country’s regulatory authority. With this launch the company has expanded its minimally invasive therapy portfolio. The new device is suitable for standard, pulsed and enhanced procedures. It has internally-cooled probes to create a lesion of various shapes, sizes and volumes.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Component
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Medtronic plc, Abbott Laboratories, Inc., Boston Scientific Corp., AngioDynamics, Inc., and Johnson & Johnson Services, Inc .
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Radiofrequency Ablation Devices Market Report Segment
By Component
- Catheter System
- Generator
- Accessories
By Application
- Oncology
- Cardiology
- Pain Management
- Others
A full report of Radiofrequency ablation (RF) Devices Market is available at: https://www.omrglobal.com/industry-reports/radiofrequency-ablation-rf-devices-market
Radiofrequency ablation (RF) Devices Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott Laboratories, Inc.
- Alcon Laboratories, Inc.
- AngioDynamics, Inc.
- AtriCure, Inc.
- Boston Scientific Corp.
- BVM Medical Ltd.
- R. Bard, Inc. (a part of Becton, Dickinson & Co.)
- CONMED Corp.
- EDAP TMS SA
- HealthTronics, Inc.
- Hologic, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
